Kezar Life Sciences, Inc. announced that John Fowler will be resigning from his role as Chief Executive Officer effective November 7, 2023, and Christopher Kirk, Ph.D. has been appointed as Chief Executive Officer. Dr. Kirk is a co-founder and member of the Board of Directors and previously served as Kezar?s President and Chief Scientific Officer from March 2015 to April 2023. Mr. Fowler will continue as a member of Kezar?s Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8049 USD | +1.89% | +1.89% | -15.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.04% | 58.6M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KZR Stock
- News Kezar Life Sciences, Inc.
- Kezar Life Sciences, Inc. Announces CEO Changes